Development of medicines
PIQ-PHARMA is proud of its developments of creating finished dosage forms. We have combined over 25 years of experience, the professionalism of technologists and the aim to make effective, safe and convenient medicines. According the growing demand for new drugs in 2013, a PIQ-PHARMA TECH technological laboratory was created in The Slava Technopark in Moscow.
Nowadays, the laboratory implements about 10 pharmaceutical development projects per year, including liquid non-sterile and solid dosage forms: tablets, hard capsules, granules, non-sterile solutions, drops, syrups, suspensions, emulsions, gels. The laboratory conducts rapid prototyping of the SFF and the development of technology for its further introduction in the enterprise production (particularly, at the PIQ-PHARMA LEK department), documentation for pharmaceutical development is processing.
PIQ-PHARMA TECH successfully implements the following tasks:
The laboratory is equipped with all the necessary equipment for conducting experiments and experimental development with subsequent adaptation to industrial production.
Technical equipment of the PIQ-PHARMA TECH laboratory:
Control and measuring equipment:
PIQ-PHARMA creates new medicines for various nosological areas with attention to the unmet needs of patients in accordance with the requirements of the EAEU and good laboratory, clinical, industrial practices.
One of the main competencies of PIQ-PHARMA is to make special children’s drugs in liquid dosage form so that doctors and parents have the opportunity to treat children from an early age.
We’re not just making medicines for adults. We consider it an important mission to create medicines that will help reduce the suffering of young patients with epilepsy as well, therefore, among other things, we are replenishing our medicine list with a special series of original and generic anticonvulsants.
PIQ-PHARMA is interested in developing its drug list. Our strategic aspirations and ongoing developments are focused primarily on the following therapeutic areas: